Instituto de Investigación Biomédica (IRB Barcelona)
Dra. Cristina Horcajada, Responsable de Innovación
C/Baldiri Reixac 10
Areas of activities
- A. Health Biotechnology
- Areas of activity
- Stem cells
- Cell cultures and mantenance
- In vitro diagnostics
- Medical devices
- Drug delivery
- Drug development
- Drug discovery
- Cellular Therapy
- Gene Therapy
- Biomaterials and tissue therapy
- Therapeutic areas
- Substance abuse
- Analgesia & Pain
- Musculoskeletal system
- Cardiovascular diseases and circulatory system
- Genetic and rare diseases
- Infectious diseases
- Inflammatory diseases
- Gynaecology and obstetrics
- Ophtalmology and optometry
- Blood and lymphatic system
- Digestive system and hepatology
- Kidney and genitourinary system
- Central nervous system
- Respiratory and pulmonary system
- Metabolic disorders / Endocrinology
- B. Agrifood Biotechnology
- Functional Food
- Vitamins and nutrition products
- D. Services
- R&D services
- Nanotechnology and in silico biology
IRB Barcelona is an independent, non-profit research institution engaged in basic and applied biomedical science that aims to improve quality of life by applying advances in this field.
Products and services
We have 5 different research programmes:
- Cell and Developmental Biology. Includes gene expression, developmental molecular biology, cell biology, functional genomics and proteomics of cell and embryo development and tissue regeneration.
- Structural and Computational Biology. Includes the structural analysis of macromolecules and their interactions usign a variety of techniques: X-ray, NMR, electron microscopy, macromolecular biophysics, bioinformatics and molecular modelling.
- Molecular Medicine. Includes the molecular bases of metabolic and genetic diseases, the study of diagnostic or therapeutic targets and the functional genomics and proteomics of pathologies and translational research.
- Chemistry and Molecular Pharmacology. Includes the design and synthesis of small molecules and macromolecules, with special emphasis on two aspects of combinatorial chemistry: the building of libraries and optimisation of the production of synthetic compounds, and biotechnologies for molecular selection directed at therapeutic targets and the establishment of the relationship between drugs and their targets.
- Oncology. Includes the study of diverse aspects of tumour initiation and progression, the relationship between stem cells and cancer, and the identification of the programmes that drive tissue-specific metastasis.